For many cannabis founders, the exit problem is not finding the right buyer. It is that there are barely any buyers at all. The field is narrow, capital is tight, and the strategic buyers that do exist are rarely showing up with clean cash offers. More [...]
In the UK, most medical cannabis, legally termed cannabis-based medicinal products (CBPMs), is prescribed by clinicians with specialist expertise, often in the private sector due to limited NHS commissioning. With this reality, issues around prescription direction, where patients are steered toward specific pharmacies or limited product lists, have become important ethical and professional considerations. This guidance aims to clarify what prescription direction means, how it relates to CBPMs, and how clinicians and patients should approach it, grounded in clinical, regulatory and prescribing standards. What Is “Prescription Direction”? ‘Prescription Direction’ refers to any practice in which a healthcare provider influences or obligates a patient to use a particular pharmacy or dispensing service to fulfil their prescription, or restricts which products may be prescribed based on a clinic’s internal formulary rather than clinical considerations alone. For standard prescription-only medicines, and CBPMs alike, once a valid prescription is issued, the patient, not the issuing clinic or prescriber, owns the prescription and has the right to have it dispensed at any appropriate pharmacy. Professional guidance makes no provision for locking prescriptions to a particular dispensing outlet on non-clinical grounds. [1] Legal and Regulatory Framework for Medical Cannabis Prescribing Who Can Prescribe CBPMs In the UK, medical cannabis products (excluding those with a marketing authorisation such as some formulations of Sativex®) are predominantly unlicensed medicines (‘specials’). The law restricts their prescription to doctors on the General Medical Council’s (GMC) Specialist Register. Specialist doctors must also only prescribe within their area of competence and clinical training. [3] NHS England guidance echoes this: while subsequent prescriptions may sometimes be made under shared care arrangements, initial prescriptions must be authorised by a specialist clinician. [2] Regulation of Clinics Prescribing Medical Cannabis Independent clinics that prescribe cannabis-based medicinal products (CBPMs), including those operating solely in the private sector, are regulated by the Care Quality Commission (CQC). The CQC sets out clear expectations for providers prescribing CBPMs, including requirements around clinical governance, prescriber competence, patient safety, informed consent, and compliance with controlled drugs legislation. The CQC guidance confirms that providers must ensure prescribing decisions are clinically justified, appropriately documented, and made in the best interests of the patient, with systems in place to manage risk and avoid conflicts of interest. This includes ensuring that organisational or commercial arrangements do not compromise professional judgement or patient choice in prescribing or supply pathways. [4] Unlicensed Medicines and Clinical Responsibility Unlicensed medicines entail additional responsibilities for prescribers because they have not undergone the full range of regulatory assessments for safety, quality and efficacy. Prescribers must therefore be confident that the product is appropriate for the individual patient, and explain to patients the unlicensed nature of the treatment as part of informed decision-making. [1][5] Supplier and Pharmacy Regulation Although there is no single official UK “list” of pharmacies that can dispense CBPMs, any pharmacy that is properly registered and complies with regulatory standards may dispense them once presented with a valid prescription. Guidance from pharmacy regulators emphasises compliance with controlled drug legislation and safe supply standards for these products. [5] Prescription Direction: Clinical and Ethical Considerations Patient Autonomy and Choice Once a specialist prescriber has written a prescription for a CBPM, the patient retains the right to choose where that prescription is dispensed. Professional standards require clinicians to respect patient autonomy and avoid practices that could restrict choice without clinical justification. The GMC’s prescribing guidance reinforces that clinicians must prescribe only within their professional competence and on clinical grounds. It does not support practices that direct patients to specific suppliers for non-clinical reasons. [1] Clinic Formularies and Product Restrictions Many private medical cannabis clinics operate internal formularies — lists of products they commonly prescribe based on clinician familiarity, supply arrangements, or existing protocols. There may be legitimate clinical reasons to prefer certain products (e.g., formulations with established pharmacological profiles or evidence bases), but clinicians must never refuse to consider other products solely because they are not on an internal clinic list, without clinical reasoning. Clinical judgement during prescribing must focus on the patient’s individual needs rather than operational convenience or commercial preference. This is consistent with all prescribing guidance for individualised care. [1] Responsibilities for Clinicians Do’s for Clinicians Respect patient choice of pharmacy: Once a valid prescription is issued, patients should be informed they may take it to any appropriately registered pharmacy capable of dispensing CBPMs. This respects patient autonomy in clinical care and supply. Provide balanced information on products: Clinicians should discuss the evidence, risks, benefits, and availability of relevant CBPMs to enable informed decision-making. Explain formulary limits transparently: If a clinic’s prescribing experience is concentrated on certain products, explicitly clarify this and discuss why other products may be considered clinically appropriate, if relevant. Follow GMC standards: Ensure prescribing decisions are based on clinical evidence and patient needs, not influenced by commercial relationships or assumptions about pharmacy supply. [1] ✔ Operate within robust clinical governance arrangements: Clinics prescribing CBPMs must meet CQC expectations for safe, effective and patient-centred care, including transparency in prescribing practices and avoidance of commercial influence on clinical decision-making. [4] Don’ts for Clinicians Do not require patients to use a particular pharmacy for non-clinical reasons. Do not imply that prescriptions are “owned” by the clinic or that patients must dispense through a preferred partner. Do not limit prescribing to products on an internal formulary if other products are clinically suitable and available. Any practice that restricts patient choice on non-clinical grounds may undermine professional ethics and patient trust. Rights and Actions for Patients Your Rights as a Patient You have the right to choose the pharmacy that dispenses your prescription, provided it is registered and authorised to supply controlled drugs and CBPMs. [5] A prescription is your legal document and may be taken to any suitable pharmacy. Clinicians must explain the clinical basis for any recommended product, including risks and benefits, to support informed consent. If You Experience Undue Direction If a clinician or clinic appears to restrict your choice of pharmacy or product without clear clinical reasoning: Ask
<p>The post Prescription Direction in Medical Cannabis: Guidance for Clinicians and Patients first appeared on PatientsCann UK®.</p>
If you are new to cannabidiol, understanding how CBD works and how to use it safely is the first step in building a confident wellness routine. Interest in CBD has grown rapidly, with many people exploring it as part of a broader approach to everyday wellbeing. For CBD beginners, learning the basics around CBD formats, dosage and safety can help you make informed choices from the start.
It starts with a routine test result. A mid-size cannabis brand discovers that a batch of infused edibles has failed a pesticide screening. Within 48 hours, the company issues a voluntary recall, pulls product from dozens of dispensary shelves, and begins fielding calls from anxious retail [...]
Missouri has quietly built one of the country’s more successful adult-use cannabis markets since launching recreational sales in 2023. Since legalization, the state has quickly grown into one of the largest cannabis markets in the Midwest, generating strong sales and supporting an expanding network of cultivators, [...]
After an intense workout, your recovery routine is just as important as the training itself. Across the world, more people are focusing on recovery wellness to support their active lifestyles, and CBD products are increasingly being included as part of these routines. From CBD Muscle Recovery Balms to CBD Patches, these options are helping individuals build simple and effective post-workout habits.
For a limited time, Supreme CBD is offering an exclusive 2-4-1 deal on 3200mg CBD Gummies. Customers can receive two tubs of 3200mg CBD gummies for the price of one by adding two tubs from the offer category to their basket and using the code FREE3200 at checkout.
While the cannabis industry has made significant strides in incorporating minor cannabinoids into product formulations, a vast number of therapeutic compounds remain largely unexplored. Researchers and cannabis physicians have been experimenting with acidic cannabinoids for several years with promising results, but the broader industry is only [...]
New research suggests that two non-psychoactive cannabis compounds could help treat fatty liver disease, the most common form of chronic liver disorder. Researchers at the Hebrew University of Jerusalem have found that Cannabidiol (CBD) and Cannabigerol (CBG), can significantly reduce liver fat and improve metabolic health [...]
Biotechnology, cannabis medicine, and the rapid advancements in artificial intelligence (AI) and machine learning (ML) are beginning to converge. Hemant Kumar Bid, program director for the Master of Science in Biotechnology and the Medical Cannabis concentration at Morehouse School of Medicine, believes this convergence could dramatically [...]
The endocannabinoid system is one of the most important regulatory systems in the human body, yet many people have never heard of it. As interest in natural wellness grows, more consumers are asking how cannabinoids interact with the body and why products like CBD are becoming part of everyday routines.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological network that remains largely untaught in medical schools despite its pivotal role in maintaining internal balance, [...]
A new UK-wide service supporting medical cannabis patients who face discrimination has launched to fill gaps left by the absence of systematic government support. Patient Protect was founded by patient advocate Alex Fraser and cannabis lawyer Robert Jappie, who have handled cases on a pro-bono basis for several years. The [...]
In these days, skincare routines are evolving. More consumers are moving towards plant-based and natural skincare solutions, particularly when dealing with everyday skin concerns such as dryness, uneven texture, redness or occasional blemishes. As a result, CBD skincare products have become increasingly popular within modern wellness routines.
Labour MP and long-time medical cannabis advocate, Tonia Antoniazzi, has called on the government to fund a new observational trial to support children with drug-resistant epilepsy, who are still unable to access medical cannabis on the NHS. Antoniazzi is spearheading a new campaign launched in memory [...]
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution in women with endometriosis-associated pain. The milestone marks a [...]
When most people think of luxury goods, they picture high-quality, high-priced products. But what truly sets luxury apart is not just cost. It is craftsmanship, design, heritage, cultural cachet, and mastery of materials and technique. Luxury is a sensory experience rooted in both tradition and innovation. [...]
As interest in cannabis compounds continues to grow, many UK consumers are searching for clear answers about CBD vs THC. While both are naturally occurring compounds found in the cannabis plant, they have very different effects, legal status and safety considerations under CBD UK law.
There’s an opportunity in the pre-roll sector that many companies are missing. The pre-roll sector is the fastest-growing category in the cannabis industry. In 2025 alone, $3.6 billion worth of pre-rolls were sold across the 14 markets tracked by cannabis analytics firm Headset. Customers love the [...]
Creatine has been one of the most researched and trusted gym supplements athletes use to support performance. But recently, a new format has started to dominate conversations in fitness communities: Creatine Gummies consumers can take without powders, shakers or mixing.
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, [...]
Maryland launched its medical cannabis program in 2018 and transitioned to adult use in 2024 as a limited-license state. Currently, there are 108 active dispensaries, with additional operators expected to come online following a March 2024 lottery that awarded conditional licenses to social equity entrepreneurs. However, [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
A new scientific review published in the National Library of Medicine (NIH) shines a spotlight on one of the most overlooked areas of cannabis science: the untapped benefits of acidic cannabinoids naturally produced by Cannabis sativa — THCA, CBDA, CBGA, and CBCA. These compounds are the [...]
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes had surpassed the pre-ban peak for the first time, reaching a new all-time high in December. [...]
2025 saw most businesses scrutinizing their operations to trim margins and survive the tumultuous market. 2026 is about digging deeper to uncover hidden costs that will further improve their bottom line. Tom Zuber, partner at Zuber Lawler, led a panel discussion at the recent IgniteNJ event, [...]
Choosing the right CBD oil strength can feel confusing, especially with so many options available across the CBD oils UK market. Whether you are new to CBD or looking to adjust your routine, understanding strength, dosage and extract type is essential for getting the most from your product.
Across the UK, more people are looking for structured ways to support emotional wellness without adding complexity to their schedules. A consistent CBD routine can offer a practical way to support everyday balance, especially for those managing busy workdays, family commitments or long commutes. The key is not quantity, but consistency.
A UK medical cannabis patient has won a Crown Court appeal after being wrongly convicted of driving with THC above the legal limit. At Winchester Crown Court on 10 February 2026, Sal Aziz, a legally prescribed medical cannabis patient, was fully acquitted of the charges after [...]
New Jersey is a highly desirable cannabis market for new operators because of its rapid billion‑dollar growth, strong consumer demand, and status as one of the most profitable yet undersupplied markets on the East Coast. Cultivators came together at the recent IgniteIt event to share their [...]
Bristol Medical School has formally approved what is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university. The move marks a significant step forward for undergraduate education in an area of practice that remains widely under-taught. Despite medical [...]
There was passion, power, and plenty of practical business advice from the women (and one man) who took the stage at the recent IgniteIt event in New Jersey. As the industry shifts away from the early “shiny-object” phase, operators are increasingly doubling down on what works. [...]
If you’ve ever searched “CBD legal UK”, you’ve likely found mixed answers. The short version is this: CBD is legal in the UK, but only if it meets strict regulations. Understanding those rules is essential for consumers who want safe, compliant products and clear CBD consumer info.
As CBD continues to become part of everyday wellness routines across the UK, many people ask the same practical question: CBD gummies or capsules? Which format fits best into daily life?
Early findings examining the impact of the partial legalisation of cannabis in Germany suggest no short-term spike in consumption or related driving offences, alongside a sharp drop in prosecutions. Researchers at the University Medical Center Hamburg-Eppendorf (UKE) in Germany have investigated the short-term effects of the [...]
Market Maturity Brings Pricing Pressure New Jersey’s cannabis market is showing signs of maturity, according to a presentation by Headset CEO Cy Scott at the recent Ignite NJ event, saying the overall revenue hit the billion-dollar mark in 2025 and is growing nominally. Similar to other [...]
CBD, short for cannabidiol, is one of the most talked-about wellness compounds in the UK today. But despite its growing popularity, many people still ask the same question: what is CBD, and how does it actually work with the body’s natural balance? This guide breaks down the essentials using clear, trustworthy CBD information for the UK marke
California’s medical cannabis market began in 1996 when voters passed Proposition 215 (the Compassionate Use Act), making it the first state to legalize cannabis for medical use. Twenty-two years later, Proposition 64 ushered in adult-use sales, which commenced in January 2018. Initially, three separate agencies handled [...]
The Super Bowl has long been one of the most important sales moments of the year for alcohol, food, and consumer packaged goods. Cannabis, however, has been left out of the conversation, often due to regulatory complexity, limited retail data, and conservative planning assumptions. However, new [...]
For many people across the UK, everyday life can feel overstimulating. Busy schedules, constant notifications and work pressures often leave people feeling unsettled, restless or struggling to fully switch off. From experience working closely with customers at Supreme CBD, one pattern is clear: people want simple, approachable ways to support calm nerves without disrupting their routine. This is where CBD Gummies are increasingly becoming the preferred option.
Unlike oils or capsules, CBD Gummies feel familiar. Often compared to CBD sweets, they fit easily into daily habits without measuring or preparation. This simplicity makes them especially appealing for those new to CBD or anyone looking for consistency. As part of the growing Edibles UK market, gummies provide a discreet, portable way to support emotional balance throughout the day.
Many people choose edibles gummies because they release cannabidiol gradually as they’re digested. This slower release can feel steadier compared to faster-acting formats, making long lasting CBD Edibles a popular choice for managing daily jitters rather than quick, short-term effects.
For individuals experiencing nervousness or mild unease, routine matters. Calm nerves gummies are often taken at the same time each day, helping people build structure into their wellness habits. This approach supports consistency, which many users find more effective than irregular use.
According to data from the Office for National Statistics, over 40% of adults in the UK report feeling stressed or unsettled at least once a week, highlighting how widespread these challenges have become. This has contributed to the rise of CBD gummies as an accessible option for everyday emotional support.
Hemp gummies are easy to carry, easy to store and discreet to use at work or while travelling. Many users browsing the CBD edibles collection prefer gummies because they don’t require additional accessories or planning.
For those seeking stronger formats, products like the Super Strength CBD Gummy Strawberries offer higher-strength options within the same familiar format, allowing users to tailor their routine without changing how they consume CBD.
Another reason gummies continue to grow in popularity is accessibility. Many options, including vegan CBD gummies UK, are designed to suit a wide range of dietary needs. Compared with other edibles UK formats, gummies often feel more enjoyable, encouraging long-term consistency rather than one-off use.
Some users also explore pairing gummies with formats found in the CBD Capsules collection to create layered routines that suit different parts of the day.
Whether you’re managing daily jitters, seeking calmer routines or looking for a straightforward entry into CBD, best CBD gummies offer a practical, approachable solution. With trusted formulations available through Supreme CBD, gummies continue to stand out as one of the most user-friendly ways to support emotional wellness.
The first administrative appeal hearing on whether Female Orgasmic Disorder (FOD) should be recognised as a qualifying condition for medical cannabis is taking place in the US state of Oregon this week. From 3 to 5 February, state officials will hear testimony from clinicians, researchers, and [...]
A new study suggests a combination approach may provide the benefits of THC treatment in Alzheimer’s with fewer negative side effects. Researchers from The University of Texas at San Antonio paired a low-dose THC extract with the selective anti-inflammatory drug celecoxib. Their findings, published in Aging and [...]
A comprehensive guide on how to read and interpret cannabis research. Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal. Every week brings new claims about cannabinoids relieving pain, aiding sleep, or reducing anxiety, yet [...]
Josh Kaplan, PhD, is a neuroscientist and associate professor in the Behavioral Neuroscience program at Western Washington University, where his lab focuses on optimizing cannabidiol (CBD) based medicines for pediatric conditions. His work examines not only CBD’s therapeutic potential, but also its long-term developmental effects on [...]
In the cannabis industry, pricing behavior often reveals more about market pressure than financial statements ever could. However, some of the most revealing cost signals are subtler, showing up in pricing behavior, discount strategies, and category-level decisions rather than on balance sheets. The CannabisDeals US Cannabis [...]
A wave of infused beverage brands flooded the market over the last few years. Now, the sector has entered a period of settling and reassessment, as operators pause to evaluate the real opportunity and determine the smartest path forward amid ongoing legal uncertainty. While adult-use cannabis [...]
Questions around Is CBD addictive are increasingly common across the CBD UK market, particularly among people looking to support emotional wellness naturally without relying on habit-forming substances. With more consumers exploring oils, gummies and wellness supplements, understanding how CBD works and how it differs from THC, is essential before adding it to a routine.
CBD (cannabidiol) and THC (tetrahydrocannabinol) are both compounds found in hemp, but they affect the body very differently. THC is responsible for the intoxicating “high” associated with cannabis, while CBD is non-intoxicating and does not produce euphoric effects. This distinction is central to CBD safety UK guidance and is why CBD is legally available in regulated wellness products.
From both clinical research and real-world, CBD does not activate the brain’s reward pathways associated with dependency. This is why CBD is not considered addictive under current scientific understanding.
According to a 2017 report by the World Health Organization, “CBD exhibits no effects indicative of any abuse or dependence potential in humans.” This conclusion has been widely referenced across global health bodies and continues to shape regulation and consumer confidence.
This evidence has helped position CBD as a supportive option for people seeking natural wellness supplements without concerns around habit formation.
Many people use CBD as part of structured emotional wellness routines, particularly during periods of stress, mental overload or disrupted sleep. Formats such as CBD Oils allow for flexible dosing, while CBD Gummies offer a convenient, consistent option for daily use.
Rather than masking emotions, CBD works by interacting with systems in the body responsible for balance and regulation. This makes it appealing to individuals seeking support for calm nerves without sedation or emotional blunting.
While CBD is not addictive, responsible use still matters. Choosing tested products, understanding serving guidance and maintaining consistency all play a role in long-term outcomes. At Supreme CBD, products across our Wellness Gummies, Vitamin Drops, Wellness Capsules, and Supreme Life range are designed to fit into everyday routines with transparency and quality control.
For anyone asking “Is CBD addictive?”, the current evidence points clearly toward no. When sourced responsibly and used as part of a thoughtful routine, CBD can support emotional wellbeing without dependency concerns.
As interest in CBD continues to grow across the UK, informed choices, grounded in science, experience and regulation, remain the key to using it with confidence.
As the cannabis industry readies for the growth surge rescheduling could trigger, it’s getting dangerously close to losing its grip on the craft sector. We are entering the era of the connoisseur, where consumer palates are becoming increasingly sophisticated and demand products that provide a full-spectrum [...]
A recent peer-reviewed paper has identified a previously unrecognised form of reporting bias that may be skewing how medical cannabis evidence is presented. The paper, published in Research Integrity and Peer Review, introduces the concept of reverse spin bias – a pattern in which authors of systematic [...]
In the first double-blind, placebo-controlled trial, vaporised cannabis was found to be more effective for treating acute migraine symptoms than a placebo. While preclinical and retrospective studies have suggested cannabinoids may be effective in migraine treatment, according to the researchers, until now, there have been no [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
